Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital
An. bras. dermatol
; 96(2): 224-227, Mar.-Apr. 2021. tab
Article
em En
| LILACS
| ID: biblio-1248740
Biblioteca responsável:
BR1.1
ABSTRACT
Abstract Leprosy is one of the neglected diseases in the world and Brazil is the second country with more cases. A retrospective study was conducted based on the medical records of 196 leprosy patients diagnosed during the course of 13 years at a university hospital. The aim was to describe the adverse effects of polychemotherapy, as well the most prevalent and most vulnerable populations. In the study, dapsone was the most implicated drug, especially in women, and the risk increased with age. The authors conclude that with this patient profile, greater vigilance should be taken regarding possible adverse effects, especially anemia.
Palavras-chave
Texto completo:
1
Índice:
LILACS
Assunto principal:
Hansenostáticos
/
Hanseníase
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
Revista:
An. bras. dermatol
Assunto da revista:
DERMATOLOGIA
Ano de publicação:
2021
Tipo de documento:
Article